Microsoft’s Chris Young on Bringing AI to Main Street

Microsoft has spent most of this year touting the promise of artificial intelligence and how it can reshape society. The job for Chris Young, head of Microsoft’s corporate strategy, is making sure that hype turns into purchases of Microsoft’s AI tools. Young leads a hundreds-strong team that works with outside partners like Facebook parent Meta … Read more

EQT Plans to Take Japan’s Benesse Private in Over $1 Billion Deal

Swedish investment company EQT plans to take Japanese education services provider Benesse Holdings private in a deal valued at more than $1 billion, by teaming up with the company’s founding family. EQT said Friday that one of its funds would spend 207.95 billion ($1.37 billion) to buy Benesse shares through an tender offer as part … Read more

Tech, Media & Telecom Roundup: Market Talk

Updated Nov. 7, 2023 4:58 pm ET The latest Market Talks covering Technology, Media and Telecom. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1637 ET – GXO Logistics reports revenue up 8% year in 3Q to $2.5 billion as more companies outsource their distribution operations to third-party logistics … Read more

China Evergrande Winding-Up Hearing Adjourned to Dec. 4

China Evergrande has been given another chance to restructure its billions of dollars in debt as a court adjourned a hearing to wind up the company. The heavily indebted Chinese property developer said that a Hong Kong High Court had moved the hearing, scheduled on Monday, to Dec. 4. Copyright ©2023 Dow Jones & Company, … Read more

Evergrande Investors Warn of 'Uncontrollable Collapse'

Evergrande’s 11th-hour cancellation of a $19 billion debt restructuring could lead to a messy collapse and have “a catastrophic effect” on other troubled companies in the sector, its bond investors said.  Source link

Bristol Myers Squibb, the biopharmaceutical company, will acquire Mirati Therapeutics in a transaction that values the oncology developer at up to $5.8 billion.

Bristol Myers Squibb, the biopharmaceutical company, will acquire Mirati Therapeutics in a transaction that values the oncology developer at up to $5.8 billion. Source link

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion

The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link

Is Bitcoin an Inflation Hedge? Here Are the Arguments on Both Sides

Two experts make their cases on whether bitcoin is protected from inflationary pressures, or is more of a speculative investment. Source link

Bankruptcy Judge Jones Named in a Lawsuit Over Romantic Relationship With Local Lawyer

A Texas bankruptcy judge has been in a romantic relationship with a lawyer whose former firm brought major chapter 11 cases to his court, a premier landing spot for corporate reorganizations. Source link

Volvo, Renault, CMA CGM to Produce Electric Vans

Volvo and Renault will launch a new company, which CMA CGM plans to join, with creation expected in early 2024, and which will operate under its own corporate identity and be based in France. Source link